MedQuist Holdings Inc. - symbol MEDH - reported the signing of a definitive agreement to acquire M*Modal - a company with current annualized revenue run rate of $24 million - and its advanced Speech Understanding technology that enable healthcare providers to easily convert speech into structured clinical information. Alcoa Inc. - symbol AA - reported that its second quarter 2011 income from continuing operations jumped 138 percent compared to a year ago on growing revenue, record quarterly alumina revenue and record mid- and down-stream performance. Finally, bio-tech stock. IsoRay Inc. - symbol ISR - announced the world’s first implant of its proprietery Cesium-131 mesh brachytherapy using the da Vinci Robotic Surgery. the benefits of Mesh Brachytherapy for patients with stage 1 lung cancer include: the most targeted radiation possible, decrease in recurrance, decrease the amount of damage done to their normal lungs and it does not involve many weeks of external radiation